Export 36 results:
Author [ Title(Desc)] Type Year
Filters: Author is Oden, Neal L  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
I. U. Scott, Oden, N. L., VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., and Antoszyk, A. N., “SCORE Study Report 7: incidence of intravitreal silicone oil droplets associated with staked-on vs luer cone syringe design.”, Am J Ophthalmol, vol. 148, no. 5, pp. 725-732.e7, 2009.
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., and Figueroa, M., “SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients With Central Retinal Vein Occlusion.”, Am J Ophthalmol, vol. 170, pp. 25-31, 2016.
A. Hendrick, VanVeldhuisen, P. C., Scott, I. U., King, J., Blodi, B. A., Ip, M. S., Khurana, R. N., and Oden, N. L., “SCORE2 Report 13: Intraretinal Hemorrhage Changes in Eyes With Central or Hemiretinal Vein Occlusion Managed With Aflibercept, Bevacizumab or Observation. Secondary Analysis of the SCORE and SCORE2 Clinical Trials.”, Am J Ophthalmol, vol. 222, pp. 185-193, 2020.
I. U. Scott, Oden, N. L., VanVeldhuisen, P. C., Ip, M. S., and Blodi, B. A., “SCORE2 Report 17: Macular Thickness Fluctuations in anti-VEGF-Treated Patients with Central or Hemiretinal Vein Occlusion”, Graefes Arch Clin Exp Ophthalmol, 2021.
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., Figueroa, M., and Dugel, P. U., “SCORE2 Report 2: Study Design and Baseline Characteristics.”, Ophthalmology, vol. 124, no. 2, pp. 245-256, 2017.
I. U. Scott, VanVeldhuisen, P. C., Ip, M. S., Blodi, B. A., Oden, N. L., Figueroa, M., and Dugel, P. U., “SCORE2 Report 2: Study Design and Baseline Characteristics.”, Ophthalmology, vol. 124, no. 2, pp. 245-256, 2017.
I. U. Scott, Oden, N. L., VanVeldhuisen, P. C., Ip, M. S., and Blodi, B. A., “SCORE2 Report 20: Relationship of Treatment Discontinuation With Visual Acuity and Central Subfield Thickness Outcomes”, Am J Ophthalmol, vol. 248, pp. 157-163, 2023.
I. U. Scott, Figueroa, M. J., Oden, N. L., Ip, M. S., Blodi, B. A., and VanVeldhuisen, P. C., “SCORE2 Report 5: Vision-Related Function in Patients With Macular Edema Secondary to Central Retinal or Hemiretinal Vein Occlusion.”, Am J Ophthalmol, vol. 184, pp. 147-156, 2017.
B. A. Blodi, Domalpally, A., Scott, I. U., Ip, M. S., Oden, N. L., Elledge, J., Warren, K., Altaweel, M. M., Kim, J. E., and Van Veldhuisen, P. C., “Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) Study system for evaluation of stereoscopic color fundus photographs and fluorescein angiograms: SCORE Study Report 9.”, Arch Ophthalmol, vol. 128, no. 9, pp. 1140-5, 2010.
A. Domalpally, Blodi, B. A., Scott, I. U., Ip, M. S., Oden, N. L., Lauer, A. K., and VanVeldhuisen, P. C., “The Standard Care vs Corticosteroid for Retinal Vein Occlusion (SCORE) study system for evaluation of optical coherence tomograms: SCORE study report 4.”, Arch Ophthalmol, vol. 127, no. 11, pp. 1461-7, 2009.
N. L. Oden and Phelps, D. L., “Statistical issues related to early closure of STOP-ROP, a group-sequential trial.”, Control Clin Trials, vol. 24, no. 1, pp. 28-38, 2003.